High-Throughput Screening Identifies Idasanutlin as a Resensitizing Drug for Venetoclax-Resistant Neuroblastoma Cells.

Summary

This is a publication. If there is no link to the publication on this page, you can try the pre-formated search via the search engines listed on this page.

Authors: Vernooij, Lindy; Bate-Eya, Laurel T; Alles, Lindy K; Lee, Jasmine Y; Koopmans, Bianca; Jonus, Hunter C; Schubert, Nil A; Schild, Linda; Lelieveld, Daphne; Egan, David A; Kerstjens, Mark; Stam, Ronald W; Koster, Jan; Goldsmith, Kelly C; Molenaar, Jan J; Dolman, M Emmy M; Afd Pharmaceutics; Pharmaceutics

Journal title: Mol Cancer Ther

Journal number: 1

Journal publisher: American Association for Cancer Research

Published year: 2021

DOI identifier: 10.1158/1535-7163.mct-20-0666

ISSN: 1535-7163